Biomarkers such as microscopic hematuria, persistent proteinuria, serum IgA levels, and the serum IgA/C3 ratio have been identified as effective for distinguishing IgAN from other kidney diseases7,8. This evidence concerns the gene CD79A and Microscopic hematuria.